Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

UACUnited Acquisition Corp. I

NYSE · CIK 0002098669
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts82

Identity from submissions API

NameUnited Acquisition Corp. I
CIK0002098669
TickersUAC, UAC-UN, UAC-WT
ExchangesNYSE, NYSE, NYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone212-847-3248
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
7100 W CAMINO REAL SUITE 302-48
BOCA RATON
FL
33433
FL
Mailing address
7100 W CAMINO REAL SUITE 302-48
BOCA RATON
FL
33433
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

36 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001076809-26-000206 005-95463 261565853 34 10834
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-463767 005-95463 261562488 34 18068
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001076809-26-000156 005-95463 261561558 34 9914
2026-11-13 10-Q 10-Q 0001493152-26-051786 001-43084 261553614 34 4355939 1 1
2026-10-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001539041-26-000038 005-95463 261471405 34 7453
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-351106 005-95463 261277806 34 17743
2026-08-12 10-Q 10-Q 0001493152-26-037369 001-43084 261267828 34 4266077 1 1
2026-05-14 10-Q 10-Q 0001493152-26-023099 001-43084 26979171 34 4050556 1 1
2026-05-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-059910 005-95463 26971473 34 26391
2026-05-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000912282-26-000687 005-95463 26964468 34 14196
2026-03-30 10-K 10-K 0001493152-26-013617 001-43084 26813713 34 4594778 1 1
2026-03-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-010610 005-95463 26763489 34 20105
2026-03-17 4 4 0001493152-26-010608 8622
2026-02-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-018782 005-95463 26659369 34 27282
2026-02-19 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-26-007514 005-95463 26656376 34 36608
2026-02-17 8-K 8-K 8.01,9.01 0001493152-26-007184 001-43084 26643325 34 334649 1 1
2026-02-13 4 4 0001493152-26-006750 7986
2026-02-13 8-K 8-K 3.02,8.01,9.01 0001493152-26-006747 001-43084 26634074 34 285632 1 1
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-039750 005-95463 26604397 34 34284
2026-02-05 8-K 8-K 8.01,9.01 0001493152-26-005310 001-43084 26603394 34 449183 1 1
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000912282-26-000259 005-95463 26602610 34 14080
2026-02-02 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0001493152-26-004605 001-43084 26585401 34 2126432 1 1
2026-01-29 424B4 424B4 0001493152-26-004195 333-291904 26576592 33 2518494
2026-01-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000327 333-291904 26574502 33 1739
2026-01-28 3 3 0001493152-26-004102 4481
2026-01-28 3 3 0001493152-26-004100 4494
2026-01-28 3 3 0001493152-26-004098 4525
2026-01-28 3 3 0001493152-26-004096 4555
2026-01-28 3 3 0001493152-26-004094 8957
2026-01-28 CERT NYSE AMERICAN CERTIFICATION 0001143313-26-000005 001-43084 26573623 34 407489
2026-01-28 8-A12B 8-A12B 0001493152-26-003922 001-43084 26570251 34 28092
2026-01-27 CORRESP filename1.htm 0001493152-26-003745 11803
2026-01-27 CORRESP filename1.htm 0001493152-26-003743 16265
2026-01-23 S-1/A S-1/A 0001493152-26-003457 333-291904 26557721 33 5236227 1 1
2026-01-16 UPLOAD filename1.pdf 0000000000-26-000605 333-291904 40120
2025-12-03 S-1 S-1 0001493152-25-025837 333-291904 251544843 33 7959804 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (82 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 774,955 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 256,669 2026-06-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037369
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 20,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037369
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 370,617 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 346,000 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD -111,455 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.53M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 346,000 2025-11-26 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap Assets Assets USD 105.99M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap AssetsCurrent Assets, Current USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 104.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 104.26M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap Capital Banking Regulation, Total Capital, Actual USD 500,000 2026-02-12 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap Cash Cash USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 1.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 4.95M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 300,000 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023099
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 330,108 2025-12-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 330,108 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.12 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.12 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -82,463 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 94,122 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 762,955 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 12,000 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 21,810 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap Liabilities Liabilities USD 4.34M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 105.99M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap LiabilitiesCurrent Liabilities, Current USD 774,955 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 104.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -101.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -869,467 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap NotesPayable Notes Payable USD 85,670 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 49,502 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -1.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 12,000 2026-01-21 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PaymentsForFees Payments for Other Fees USD 652 2025-11-26 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PaymentsForRent Payments for Rent USD 20,000 2026-01-28 2026 Q1 10-Q 2026-05-14 0001493152-26-023099
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 468,990 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 101.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 25,429 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 35,744 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 63,805 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 100.30M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023099
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 2.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 101.82M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 36,000 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -97,671 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-023099
us-gaap ProfessionalFees Professional Fees USD 160,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 97,671 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -2.48M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap SaleOfStockPercentageOfOwnershipBeforeTransaction Sale of Stock, Percentage of Ownership before Transaction pure 0.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 346,000 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap SharePrice Share Price USD/shares 11.5 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap ShortTermBorrowings Short-term Debt USD 97,671 2026-01-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -2.48M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2.77M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 1.75M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 904,796 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 104.13M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001493152-26-051786
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 2.41M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001493152-26-037369
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 3.33M 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.33M 2025-10-22 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013617

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →